EUROQOL | News
NICE commissions expert advice on EQ-5D-5L valuation set for England
Working in partnership with the Department of Health and Social Care, NICE has commissioned four international experts to review the quality of data and the modelling techniques used to derive the EQ-5D-5L valuation set for…
EuroQol introduces the Interviewer Administered versions
The 3L and 5L Interviewer Administered versions (IA) were developed as amalgamated single versions to replace the Face-to-face and Telephone administered versions. This was done to facilitate the translation process, reduce costs to the users…
Snapshot of EuroQol research and interests published in Value in Health
A series of papers on the EQ-5D has been published in the latest issue of Value in Health (ViH). Curated by guest editor and EuroQol Member, Andrew Lloyd, the themed section includes an overview of…
EuroQol extends free use of EQ-5D for non-commercial users
The Board of the EuroQol Research Foundation regularly reviews the EQ-5D user license policy. Recently, a decision has been made to extend free use to all non-commercial users. Therefore, as of today, 18 January 2019,…
New version of the EQ-5D-3L User Guide now available for download!
The EuroQol Office published a new version of the EQ-5D-3L User Guide, which is is now available for download at the EuroQol website: A change to the EQ-5D-3L, reflected in this User Guide update, has…
Update on the EQ-5D-5L Value Set for England
The following is an update on the current situation regarding the EQ-5D-5L value set for England. The EQ-5D-5L value set for England was published in 2018. Since then, in line with UK government quality assurance…
In just one year, nearly 5,000 requests submitted to use the EQ-5D
The EQ-5D has been used in clinical trials, population studies, and real world clinical settings for over 25 years and interest in using the instrument remains as strong as ever. From 1 October 2017 to…
Congratulations to PhD graduates!
EuroQol Office team film
The EuroQol Office team is based in Rotterdam, the Netherlands, and supports the EuroQol Research Foundation, the EuroQol Group Association and its members. We recently produced a brief film on the EuroQol Office team, see…
EQ-5D is a recommended tool for use in cost-utility analyses around the globe
A recent literature search, supplemented with information provided by EuroQol members, revealed that EQ-5D is the recommended tool for use in cost-utility analysis by a number of Health Technology Assessment bodies around the globe (including…